Access cutting-edge autism spectrum disorder treatment through this clinical trial at a research site in Charlottesville. Study-provided care at no cost to qualified participants.
Access autism spectrum disorder specialists in Charlottesville at no cost
This study follows strict safety protocols and ethical guidelines
All study-related autism spectrum disorder treatment provided free
This is a randomized, double blind, placebo-controlled study of the effects of intranasal oxytocin on bone health in children with autism spectrum disorder, ages 6-18 years old. Subjects will be randomized to receive intranasal oxytocin or placebo (30 IU, 2 times daily) for 12 months in the double-blind phase, followed by a 6-month open label phase during which all study subjects will receive intranasal oxytocin (30 IU, 2 times daily). Study visits include screening to determine eligibility, fol
Sponsor: Elizabeth Austen Lawson
Check if you qualify for this autism spectrum disorder clinical trial in Charlottesville, VA
If you're searching for autism spectrum disorder treatment options in Charlottesville, VA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Charlottesville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced autism spectrum disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.